AVPR2 and inborn mitochondrial metabolism disorder: Thus, as already applied for mitochondrial diseases [57], we propose NDI1 as a useful tool to uncover NADH dehydrogenase inhibition in specific tumor cells and bypass it in order to assess its potential contribution to neoplastic transformation.